Literature DB >> 9070879

Differential migration of acylphosphatase isoenzymes from cytoplasm to nucleus during apoptotic cell death.

P Chiarugi1, D Degl'Innocenti, G Raugei, T Fiaschi, G Ramponi.   

Abstract

The subcellular distribution of both muscle and common type acylphosphatases was studied during apoptosis. Both isoenzymes were previously shown to have in vitro nucleolytic activity having a pH optimum at 6.8. In this paper we demonstrate a nuclear migration of the muscle type isoenzyme in response to various apoptotic stimuli either in K562 or in Jurkat cells, while the common type acylphosphatase isoform remains cytoplasmatic under the same conditions. Furthermore, we present evidences of a direct in vivo interaction between muscle acylphosphatase and two other DNAses of about 60 and 80 kDa in size. Our results are consistent with an in vivo involvement of the muscle isoform in apoptosis, possibly as a part of a multimeric protein complex that binds and hydrolyses DNA during this process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070879     DOI: 10.1006/bbrc.1997.6176

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Mechanism of acylphosphatase inactivation by Woodward's reagent K.

Authors:  P Paoli; T Fiaschi; P Cirri; G Camici; G Manao; G Cappugi; G Raugei; G Moneti; G Ramponi
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

2.  Common-type acylphosphatase: steady-state kinetics and leaving-group dependence.

Authors:  P Paoli; P Cirri; L Camici; G Manao; G Cappugi; G Moneti; G Pieraccini; G Camici; G Ramponi
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

3.  Acylphosphatase possesses nucleoside triphosphatase and nucleoside diphosphatase activities.

Authors:  P Paoli; G Camici; G Manao; E Giannoni; G Ramponi
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

4.  SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma.

Authors:  Austin L Brown; Philip J Lupo; Mehmet Fatih Okcu; Ching C Lau; Surya Rednam; Michael E Scheurer
Journal:  Cancer Med       Date:  2015-09-24       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.